Top Stories
The Eleven Therapeutics spinout is starting with kidney and vascular diseases, where it says known genetic targets have remained difficult to reach with existing medicines.
The goal of the collaboration is to standardise tissue analysis and accelerate biomarker research, supporting drug development efforts.
The blood-based assay is designed to detect multiple cancers and pinpoint where they may have originated, potentially helping guide follow-up investigations.
Sava is targeting CE approval for a sensor that could guide insulin dosing without routine fingerstick checks.
The drugmaker said it tested Chai's models across a panel of diverse targets and saw designs with "strong binding affinities."
Conference News
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Findings report on ability to measure cellular and soluble inflammatory protein biomarkers in sputum, including biologic drug targetsCompany advances research and development in diagnostic tests for m...
UPPSALA, SE / ACCESS Newswire / October 13, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announced the upcoming la...
Expansion will help life sciences teams explore patient populations, assess study feasibility, and generate insights across the US, UK, Germany, and JapanNEW YORK--(BUSINESS WIRE)-- Flatiron Health to...
DETECT-ME study evaluates a non-endoscopic, methylation-based approach to identifying Barrett’s esophagus across 18 U.S. sitesNASHVILLE, Tenn.--(BUSINESS WIRE)-- Cyted Health:WHATCyted Health will pre...



